This is the second post in Bill of Health's symposium on the Law, Ethics, and Science of Re-Identification Demonstrations.
This post is part of Bill of Health's symposium on the Law, Ethics, and Science of Re-Identification Demonstrations.
In Part 1 and Part 2 of this symposium contribution I wrote about a number of re-identification demonstrations and their reporting, both by the popular press and in scientific communications.
By Jen Wagner, J.D., Ph.D. Before I actually discuss my thoughts on the re-identification demonstrations, I think it would be useful to provide a brief background on my perspective.
While each separate reporting concern that I've addressed here is important in and of itself, the broader pattern that can be observed for these communications about re-identification demonstrations raises some serious concerns about the impact that such distortive reporting could have on the development of sound and prudent public policy for the use of de-identified data.
In the aftermath of the recent re-identification demonstrations (Gymrek et al. 2013; Homer et al. 2008), concerns have been raised by, inter alia, the actual participants of personal genomic data sharing projects pointing out that the non-consensual re-identification attempts are ethically reprehensible (Meyer 2013).
Nevertheless, the identification, characterization, and demonstration of the estrogen-binding characteristics of GPR30 certainly merit serious consideration by breast cancer researchers that it is a potentially important player in estrogen signaling in the breast.
Father's Day weekend workshops tomorrow in the park from 1 to 2 30 p.m. "Catch-and-Release," with fish identification and fly-tying demonstrations, at the Harlem Meer, Charles A. Dana Discovery Center, 110th Street near Fifth Avenue, (212) 860-1370.
This first demonstration of identification of symbolically-evoked thoughts opens the possibility of studying the neural representation of virtually any concept that can be communicated.
Identification was confirmed through demonstration of the growth of characteristic colonies on bird seed agar and API 32C sugar assimilation tests (BioMerieux SA, Marcy l'Etoile, France).
Sol Snyder and colleagues discovered the opiate receptors in brain using a radioligand binding assay (41), assisting the demonstration and identification of endogenous opioid peptides and their myriad biological functions.
